Update on Proposed Acquisition of Putney, Inc.

RNS Number : 3907V

Dechra Pharmaceuticals PLC

15 April 2016

 

THIS ANNOUNCEMENT IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, RELEASE OR DISTRIBUTION WOULD BE UNLAWFUL.  THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE AN OFFER OR AN INVITATION TO ACQUIRE OR DISPOSE OF ANY SECURITIES. 

15 April 2016

Dechra^® Pharmaceuticals PLC

(Dechra or the Company) 

Update on Proposed Acquisition of Putney, Inc.

Further to the announcement on 15 March 2016 regarding the proposed acquisition of Putney, Inc. ("Putney"), Dechra Pharmaceuticals is pleased to provide an update on the clearance sought from the United States Department of Justice and the United States Federal Trade Commission in connection with the transaction.

The mandatory waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, has now expired.

The expiration of the waiting period satisfies the primary condition to the closing of the proposed acquisition, which is now expected to complete by 21 April 2016.

Enquiries:

Dechra Pharmaceuticals PLC
Ian Page, Chief Executive Officer Anne-Francoise Nesmes, Chief Financial Officer	Office: [phone] Email: [e-mail]
Investec
Chris Treneman Daniel Adams Matt Lewis Jonathan Wynn	Tel:  [phone]
TooleyStreet Communications Ltd
Fiona Tooley, Director	Mobile: [phone] Email: [e-mail]

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and related products business.  Our expertise is in the development, manufacture and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

 

END

 

 

MSCAKPDNNBKDAQD